GP
GreenPower Motor Company Inc.
There isn't enough reported data to score GP yet.
TSLA
Tesla, Inc.
TSLA's fundamentals are mixed, but it looks expensive: trading at 437x earnings, more than twice its usual 175x. Analysts expect earnings growth, though they disagree widely on how much.
GP Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Weak | |
| Unavailable |
GP's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
GP PE Valuation
GP has no meaningful PE right now: it lost money over the past year.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.
GP Forward outlook
There aren't enough analyst estimates for GP to show an outlook.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for TSLA, with profitability holding steady. However, they disagree widely on these estimates.
GP Earnings Per Share
GP and TSLA do not have enough comparable growth data to identify a winner.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA's earnings per share have fallen from their peak: $0.91 over the past year, against $4.30 in late 2023.
GP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $439.1K | -72% |
| Q1 2026 | $3.9M | -10% |
| Q4 2025 | $8.5M | +18% |
| Q3 2025 | $2.5M | -53% |
| Q2 2025 | $1.5M | -48% |
| Q1 2025 | $4.3M | -16% |
| Q4 2024 | $7.2M | -12% |
| Q3 2024 | $5.3M | -37% |
GP's revenue has slid since its 2023 peak: $439,148 last quarter, down 72% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -367% | -136 points |
| Q1 2026 | 1.7% | +129 points |
| Q4 2025 | 58% | N/A |
| Q3 2025 | -118% | N/A |
| Q2 2025 | -231% | N/A |
| Q1 2025 | -127% | N/A |
| Q4 2023 | -53% | -30 points |
| Q3 2023 | -47% | -7.3 points |
GP's operating margin was −367% last quarter, down 136 points from the same quarter a year ago, near the bottom of its range since 2019.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA has the edge over GP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA has the edge over GP on profitability, with a higher operating margin.
GP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.3M | +$111.7K |
| Q1 2026 | -$3.7M | -$3.3M |
| Q4 2025 | -$1.2M | -$131.2K |
| Q3 2025 | $173.2K | +$1.5M |
| Q2 2025 | -$1.4M | +$1.9M |
| Q1 2025 | -$390.8K | +$4.6M |
| Q4 2024 | -$1.1M | -186% |
| Q3 2024 | -$1.4M | +$4.1M |
GP has burned cash in most quarters: −$6M over the past year, against −$4M the year before.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA has the edge over GP on cash generation, producing positive trailing cash flow while its opponent burns cash.
GP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +99% | +562K shares |
| 1 year | +127% | +633K shares |
GP has 1M diluted shares, up 127% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2023 | — |
| Q3 2023 | — |
GP hasn't bought back shares in the past year.
TSLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1M shares |
| 1 year | +0.4% | +15M shares |
| 3 years | +1.4% | +48M shares |
| 5 years | +5.1% | +172M shares |
| Available history | +33% | +886M shares |
TSLA has the edge over GP on shareholder dilution, with a more favorable share count trend.
GP Net Leverage
GP's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has more cash than debt.
GP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.6 | Neutral |
| Stochastic | 3.8 | Oversold |
GP's weekly RSI is 31 (neutral) and its Stochastic is 4 (oversold).
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
GP PE vs Consumer Cyclical Sector
GP has no meaningful PE right now: it lost money over the past year.
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
GP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.70 | 28% below |
| 20 week MA | $4.72 | 74% below |
| 50 week MA | $5.04 | 76% below |
| 100 week MA | $14.0 | 91% below |
| 200 week MA | $64.0 | 98% below |
GP is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has the edge over GP on trend strength, trading above more of its moving averages.
GP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $76.7 | $1,134.5 | +1380% |
| 2021 | $1,134.5 | $443.0 | -61% |
| 2022 | $443.0 | $96.5 | -78% |
| 2023 | $96.5 | $156.5 | +62% |
| 2024 | $156.5 | $37.9 | -76% |
| 2025 | $37.9 | $4.17 | -89% |
| 2026 YTD | $4.17 | $1.23 | -71% |
GP's yearly returns have swung widely, from +1380% in 2020 to −89% in 2025. It's down 71% so far in 2026.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA has the edge over GP on returns for 2026, with the stronger performance.